Status:
COMPLETED
Colchicine Plus Phenolic Monoterpenes to Treat COVID-19
Lead Sponsor:
Kermanshah University of Medical Sciences
Conditions:
COVID-19
Eligibility:
All Genders
10+ years
Phase:
PHASE1
PHASE2
Brief Summary
In this randomized controlled clinical trial, defined cases of COVID-19 with mild, moderate, or severe pneumonia (according to the NIH guideline) were treated with conventional treatment regimens (con...
Eligibility Criteria
Inclusion
- Defined cases of COVID-19 based on laboratory and/or radiological and clinical manifestation
Exclusion
- Age \<10, Pregnancy, Sever kidney dysfunction, Previous history of allergy to Colchicine, not willing to sign informed consent form
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04392141
Start Date
April 1 2020
End Date
November 1 2020
Last Update
April 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Kermanshah, Iran, 083